Pharmaceuticals

Back to Life Sciences & Healthcare

With ever increasing costs of gaining marketing authorisations for new drugs, fewer opportunities for blockbuster products and ongoing pressure on pricing, operating successfully in the pharmaceutical sector can be challenging. Our sector-focused team, many of whom have technical backgrounds, are able to help clients overcome these challenges and maximise the commercial opportunities.

Operating in one of the most highly regulated sectors, you need lawyers who are leaders in their field. We have expertise in the regulation of medicines, clinical trials, promotion and marketing, anti-corruption and industry codes, IP, data protection, competition, public procurement, tax and transfer pricing.

Whether you are looking to acquire a developmental pipeline from another company or streamline your own pipeline/portfolio to focus on particular therapeutic areas, we have relevant experience advising on product acquisition and disposal, R&D collaboration, supply chain, and licensing agreements. Having acted on large cross-border licensing and M&A deals for our sector-leading clients, our multi-disciplinary team can advise on transactions of any size and complexity.

We also represent clients in domestic and cross-border litigation, whether relating to commercial disputes, defence of product liability claims, protecting intellectual property rights or judicial review and public procurement challenges.

Highlights of our experience in Pharmaceuticals in the UK
Almirall, S.A. on the transfer of its respiratory franchise for an initial consideration of USD 875m on completion, and up to USD 1.22bn in development, launch and sales-related milestone payments. Takeda...
Law-Now: Lifesciences
Visit Law-Now for legal know-how and commentary
Advising the Board

Feed

30/10/2019
CMS advises Advent International and Zentiva on acquisition of Alvogen’s...
International law firm CMS has advised global private equity firm Advent International and its portfolio company, Zentiva, on its acquisition of the CEE business of global generic and over-the-counter...
04/06/2019
Future Leaders
We are pleased to invite you to the latest seminar in our 'Future Leaders Seminar Series' which is run by less senior members of our team for the benefit of junior in-house lawyers and other professionals...
29/11/2018
(Webinar) Vital Signs
The UK Life Sciences sector welcomed Sir John Bell’s Life Sciences Industrial Strategy last year. Its bold vision and ambition have the potential to drive a new era of growth. But as a new survey by...
19/09/2018
Future Leaders Seminar Series
We are pleased to announce the third seminar in our 'Future Leaders Seminar Series' which is run by less senior members of our team for the benefit of junior in-house lawyers and other professionals...
20/06/2018
Innovation in the Cloud - Reducing IP Risk for the Life Sciences and Healthcare...
New technologies like cloud computing are transforming the Life Sciences industry. Many businesses now incorporate data analytics and software development into their core operations. In the process, healthcare...
21/06/2017
Lifesciences Webinars: Spring Series 2017
We are delighted to invite you to the Spring Webinar Series hosted by the CMS Lifesciences Sector Group. The series has been designed to give you and your colleagues an overview of the legal aspects of...
21/06/2017
Lifesciences Webinars: Spring Series 2017
We are delighted to invite you to the Spring Webinar Series hosted by the CMS Lifesciences Sector Group. The series has been designed to give you and your colleagues an overview of the legal aspects of...
11/05/2017
Lifesciences Webinars: Spring Series 2017
We are delighted to invite you to the Spring Webinar Series hosted by the CMS Lifesciences Sector Group. The series has been designed to give you and your colleagues an overview of the legal aspects of...
15/12/2016
Webinar Series: Lifesciences 2016
On behalf of the CMS Lifesciences sector group, we are pleased to invite you to a series of webinars in which we will draw on experts from across the CMS network to give multi-jur­is­dic­tion­al views on...